Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56.2M
-
Number of holders
-
427
-
Total 13F shares, excl. options
-
56.2M
-
Shares change
-
+892K
-
Total reported value, excl. options
-
$8.09B
-
Value change
-
+$126M
-
Put/Call ratio
-
1.91
-
Number of buys
-
178
-
Number of sells
-
-219
-
Price
-
$143.94
Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q4 2024
515 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q4 2024.
REPLIGEN CORP - COMMON STOCK (RGEN) has 427 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56.2M shares
.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (7.14M shares), BlackRock, Inc. (6.86M shares), VANGUARD GROUP INC (5.1M shares), STATE STREET CORP (1.69M shares), Champlain Investment Partners, LLC (1.54M shares), SANDS CAPITAL MANAGEMENT, LLC (1.36M shares), Bank of New York Mellon Corp (1.35M shares), CITADEL ADVISORS LLC (1.18M shares), MACQUARIE GROUP LTD (1.1M shares), and Impax Asset Management Group plc (1.05M shares).
This table shows the top 427 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.